Amiodarone Litigation
If you believe you or a family member have been the victim of negligent prescription of Amiodarone or Cordarone, now is the time to call our firm because English Law Group PLLC represents plaintiffs in the suit forming the nucleus of In re: Amiodarone Toxicity Litigation.
In this suit, we allege that Wyeth Pharmaceuticals, Sandoz Pharmaceuticals, Novartis Pharmaceuticals, and Eon Labs (which manufacture the generic Amiodarone) manufactured and marketed these dangerous drugs to the medical community who prescribed them for off label routine treatment of atrial fibrillation and atrial flutter when the Physician’s Desk Reference (PDR) notes these drugs should ONLY be used as a drug of last choice for these conditions in persons over age 80 who have failed in other medical management and are facing severe limitation in quality of life. Quite the opposite, due to the marketing efforts of these manufacturers Amiodarone is one of the most widely prescribed drugs in the US for an off-label use. For example, the United States Government paid $13.4 billion dollars in reimbursements for the drug last year due to mis-prescription and dangerous use.
English Law Group PLLC looks forward to taking a leadership role in the national litigation and will be among counsel present in Chicago, IL on May 26, 2016 to present arguments before The Judicial Panel on Multi-District Litigation.
Have questions? Need assistance? You may call our office at 214.528.4300. We are here to assist you with your case.
In this suit, we allege that Wyeth Pharmaceuticals, Sandoz Pharmaceuticals, Novartis Pharmaceuticals, and Eon Labs (which manufacture the generic Amiodarone) manufactured and marketed these dangerous drugs to the medical community who prescribed them for off label routine treatment of atrial fibrillation and atrial flutter when the Physician’s Desk Reference (PDR) notes these drugs should ONLY be used as a drug of last choice for these conditions in persons over age 80 who have failed in other medical management and are facing severe limitation in quality of life. Quite the opposite, due to the marketing efforts of these manufacturers Amiodarone is one of the most widely prescribed drugs in the US for an off-label use. For example, the United States Government paid $13.4 billion dollars in reimbursements for the drug last year due to mis-prescription and dangerous use.
English Law Group PLLC looks forward to taking a leadership role in the national litigation and will be among counsel present in Chicago, IL on May 26, 2016 to present arguments before The Judicial Panel on Multi-District Litigation.
Have questions? Need assistance? You may call our office at 214.528.4300. We are here to assist you with your case.
